SC
AGN

Saybrook Capital’s Allergan plc AGN Stock Holding History

Saybrook Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3,264
Closed -$669K – 53
2017
Q3 		$669K Sell
3,264
-15,520
-83% -$3.61M 0.33% 38
2017
Q2 		$4.57M Buy
18,784
+3,451
+23% +$811K 2.29% 23
2017
Q1 		$3.66M Buy
15,333
+1,425
+10% +$332K 1.98% 23
2016
Q4 		$2.92M Sell
13,908
-9,419
-40% -$1.95M 1.85% 23
2016
Q3 		$5.37M Buy
23,327
+8,226
+54% +$2.01M 3.43% 15
2016
Q2 		$3.49M Sell
15,101
-2,160
-13% -$498K 2.26% 22
2016
Q1 		$4.63M Buy
17,261
+1,014
+6% +$290K 2.93% 18
2015
Q4 		$5.08M Sell
16,247
-1,690
-9% -$503K 3.22% 16
2015
Q3 		$4.88M Buy
17,937
+478
+3% +$147K 3.27% 16
2015
Q2 		$5.3M Buy
17,459
+581
+3% +$173K 3.38% 14
2015
Q1 		$5.02M Buy
16,878
+14,828
+723% +$4.23M 3.31% 16
2014
Q4 		$528K Buy
+2,050
New +$512K 0.31% 37

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Saybrook Capital's AGN Position: Q4 2017 in Review

Saybrook Capital sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 3,264 shares — an estimated $669K sold.

Saybrook Capital first reported a position in AGN in Q4 2014 and held it in 12 quarters. The position peaked at $5.37M in Q3 2016. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Saybrook Capital reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Saybrook Capital sold 3,264 Allergan plc shares in Q4 2017, an estimated $669K.
  • Saybrook Capital first reported a position in Allergan plc in Q4 2014 and held it in 12 quarters.
  • Saybrook Capital's Allergan plc position peaked at $5.37M in Q3 2016.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Saybrook Capital's 13F filing for Q4 2017, filed 14 Feb 2018.